Found 22 matching trials
Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer PHASE1 The objective of this phase I/ II study is therefore to assess the safety a...
Show More Location
Centre Georges François Leclerc
Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer PHASE2 This is a Phase II, randomized, open-label, multi-center study evaluating t...
Show More Location
Multiple Locations
Learn More & Join Trial
A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin PHASE2 This is a randomized controlled trial of HER-2 positive breast cancer patie...
Show More Learn More & Join Trial
A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer PHASE1 This study is an open-label, dose-escalation study of MM-111 with five diff...
Show More Location
Rocky Mountain Cancer Centers
Learn More & Join Trial
GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer PHASE1 This study was designed to be two-part study (Phase I/Phase II). Part I was...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D PHASE3 This was a four-arm (parallel group) randomized, open-label, multicenter Ph...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer PHASE1 RATIONALE: Drugs used in chemotherapy, such as docetaxel, fluorouracil, epi...
Show More Location
C.H.U. Sart-Tilman
Learn More & Join Trial
Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients PHASE2 Phase II randomized multicenter trial to compare Epirubicin and Cyclophosph...
Show More Location
Hospital Germans Trias i Pujol
Learn More & Join Trial
A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients. PHASE2 The primary objective:
-To assess the efficacy of TCH and TCHL in neo-adju...
Show More Location
St James's Hospital
Learn More & Join Trial